Effectiveness of the various revascularization techniques in multivessel coronary artery disease: a systematic review

I Komang Adhi Parama Harta1, Putu Febry Krisna Pertiwi2, I Gde Julia Arta3

  • 1Cardiothoracic and Vascular Surgery Division, Department of Surgery, Faculty of Medicine, Udayana University, Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali, Indonesia.

Annals of Medicine
|September 30, 2025
PubMed

Insights

Off-pump coronary artery bypass (OPCAB) techniques, especially anaortic OPCAB (anOPCAB), reduce early mortality and stroke risk in multivessel coronary artery disease (MVD) patients. These methods offer better revascularization than percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Evidence-Based Medicine

Background:

  • Multivessel coronary artery disease (MVD) necessitates revascularization, but optimal strategies for reducing stroke and achieving complete revascularization are debated.
  • Existing research lacks definitive comparisons of various revascularization techniques regarding key clinical outcomes.

Purpose of the Study:

  • To systematically compare major revascularization strategies for MVD.
  • To evaluate effectiveness in reducing early mortality, stroke, postoperative atrial fibrillation (POAF), and renal failure.
  • To assess the rate of complete revascularization across different techniques.

Main Methods:

  • A systematic review and network meta-analysis of 32 studies involving 65,861 patients.
  • Comparison of five techniques: on-pump coronary artery bypass (ONCAB), off-pump coronary artery bypass (OPCAB), OPCAB with proximal anastomotic device (OPCAB-PAD), anaortic OPCAB (anOPCAB), and percutaneous coronary intervention (PCI).
  • Statistical analysis using random effects models to calculate odds ratios (ORs) and 95% confidence intervals (CIs); risk of bias assessed using RoB2 and ROBINS-I tools.

Main Results:

  • Anaortic OPCAB (anOPCAB), OPCAB-PAD, and OPCAB showed significantly lower early mortality compared to ONCAB.
  • Stroke risk was substantially reduced with anOPCAB and OPCAB-PAD versus ONCAB.
  • All surgical approaches achieved superior complete revascularization rates compared to PCI.
  • anOPCAB demonstrated significantly lower rates of POAF and renal failure than ONCAB.

Conclusions:

  • Off-pump techniques, particularly anOPCAB, offer significant advantages in reducing stroke risk and improving early mortality in MVD patients.
  • These off-pump strategies provide comparable or superior revascularization outcomes to ONCAB.
  • Percutaneous coronary intervention (PCI) is associated with incomplete revascularization, suggesting its primary role in high-surgical-risk patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
237
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K